Propofol-Induced Rhabdomyolysis: A Case Report

Zhi-Bin Zhou,Xiao-Yu Yang,Xue Zhou,Li-Jun Niu,Liang-Can Xiao,Wen-Qi Huang,Xia Feng
DOI: https://doi.org/10.5414/cp202341
2015-01-01
International Journal of Clinical Pharmacology and Therapeutics
Abstract:OBJECTIVETo report a case of propofol-induced rhabdomyolysis. In this case, widespread myolysis was detected after induction of anesthesia.CASE SUMMARYA 54-year-old female patient was scheduled for a hysterectomy. Beginning shortly after the induction of anesthesia with propofol, several episodes of ventricular fibrillation occurred. Despite intensive care, the patient failed to recover. During most episodes of ventricular fibrillation, marked hyperthermia or hyperkalemia were not observed. Unexplained, widespread myolysis affecting both skeletal and cardiac muscle was observed at autopsy.DISCUSSIONIn this patient, the evidence for rhabdomyolysis is robust. Clinical characteristics are similar to those observed in propofol infusion syndrome. The absence of a body temperature over 40 °C precludes the possibility of malignant hyperthermia. Widespread rhabdomyolysis locations cannot be explained by precordial electric shocks. Propofol is the only drug used in this case that has been reported to induce rhabodomyolysis.CONCLUSIONSSigns of propofol-induced rhabdomyolysis may be different from those of malignant hyperthermia. Even a regular induction dose of propofol for adults could possibly trigger rhabdomyolysis similar to what is observed in children diagnosed with propofol infusion syndrome. Though rare, care should still be taken when administering propofol.
What problem does this paper attempt to address?